Susquehanna International Group’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History
Bought
Maintained
Sold
Susquehanna International Group's HARP Position: Q2 2023 in Review
Susquehanna International Group sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q2 2023, closing a stake of 5,395 shares — an estimated $40.1K sold.
Susquehanna International Group first reported a position in HARP in Q3 2020 and held it in 10 quarters. The position peaked at $1.9M in Q1 2021. 44 funds tracked by Wall St. Rank hold HARP as of Q2 2023.
- Susquehanna International Group reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
- Susquehanna International Group sold 5,395 Harpoon Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $40.1K.
- Susquehanna International Group first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q3 2020 and held it in 10 quarters.
- Susquehanna International Group's Harpoon Therapeutics, Inc. Common Stock position peaked at $1.9M in Q1 2021.
- 44 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q2 2023.
Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.